Overexpression of the natural antisense hypoxia-inducible factor-1α transcript is associated with malignant pheochromocytoma/paraganglioma

Endocrine-Related Cancer

Volumn 18, Issue 3, 2011, Pages 323-331

  Span, P N ^a   Rao, J U ^a   Oude Ophuis, S B J ^a   Lenders, J W M ^a,c   Sweep, F C G J ^a   Wesseling, P ^a   Kusters, B ^a   Van Nederveen, F H ^b   De Krijger, R R ^b   Hermus, A R M M ^a   Timmers, H J L M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^c UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 3; CYTOCHROME B5; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SUCCINATE DEHYDROGENASE; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ANTISENSE THERAPY; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHEOCHROMOCYTOMA; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; AQUAPORIN 3; CHILD; CYCLIN-DEPENDENT KINASE INHIBITOR P57; CYTOCHROME B GROUP; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PHEOCHROMOCYTOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 79960098218     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-10-0184     Document Type: Article

References (37)

1. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV & Neckers LM 1998 Stabilization of wild-type p53 by hypoxia-inducible factor 1alpha. Nature 392 405-408. (doi:10.1038/32925)
2. Baysal BE 2008 Clinical and molecular progress in hereditary paraganglioma. Journal of Medical Genetics 45 689-694. (doi:10.1136/jmg.2008. 058560)
3. Bolland DJ, Wood AL, Johnston CM, Bunting SF, Morgan G, Chakalova L, Fraser PJ & Corcoran AE 2004 Antisense intergenic transcription in V(D)J recombination. Nature Immunology 5 630-637. (doi:10.1038/ni1068)
4. Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A et al. 2010 SDHA is a tumor suppressor gene causing paraganglioma. Human Molecular Genetics 19 3011-3020. (doi:10.1093/hmg/ddq206)
5. Cayre A, Rossignol F, Clottes E & Penault-Llorca F 2003 aHIF but not HIF-1alpha transcript is a poor prognostic marker in human breast cancer. Breast Cancer Research 5 R223-R230. (doi:10.1186/bcr652)
6. Chen J, Sun M, Kent WJ, Huang X, Xie H, Wang W, Zhou G, Shi RZ & Rowley JD 2004 Over 20% of human transcripts might form sense-antisense pairs. Nucleic Acids Research 32 4812-4820. (doi:10.1093/nar/gkh818)
7. Dahia PL, Ross KN, Wright ME, Hayashida CY, Santagata S, Barontini M, Kung AL, Sanso G, Powers JF, Tischler AS et al. 2005 A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas. PLoS Genetics 1 72-80. (doi:10.1371/journal.pgen.0010008)
8. DeLellis RA, Lloyd RV, Heitz PU & Eng C 2004 Pathology and Genetics. In World Health Organization Classification of Tumours of Endocrine Organs, ch 3, pp 151-166. Lyon, France: IARC Press.
9. Eisenhofer G, Bornstein SR, Brouwers FM, Cheung NK, Dahia PL, de Krijger RR, Giordano TJ, Greene LA, Goldstein DS, Lehnert H et al. 2004 Malignant pheochromocytoma: current status and initiatives for future progress. Endocrine-Related Cancer 11 423-436. (doi:10.1677/erc.1.00829)
10. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD & Semenza GL 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology 16 4604-4613. (Pubitemid 26272112)
11. Gimenez-Roqueplo AP, Favier J, Rustin P, Mourad JJ, Plouin PF, Corvol P, Rötig A & Jeunemaitre X 2001 The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. American Journal of Human Genetics 69 1186-1197. (doi:10.1086/324413)
12. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Kerlan V, Plouin PF, Rötig A & Jeunemaitre X 2002 Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma. Journal of Clinical Endocrinology and Metabolism 87 4771-4774. (doi:10.1210/jc.2002-020525)
13. Gimenez-Roqueplo AP, Burnichon N, Amar L, Favier J, Jeunemaitre X & Plouin PF 2008 Recent advances in the genetics of phaeochromocytoma and functional paraganglioma. Clinical and Experimental Pharmacology & Physiology 35 376-379. (doi:10.1111/j.1440-1681.2008.04881.x)
14. Gottlieb E & Tomlinson IP 2005 Mitochondrial tumour suppressors: a genetic and biochemical update. Nature Reviews. Cancer 5 857-866. (doi:10.1038/nrc1737)
15. Häyry V, Salmenkivi K, Arola J, Heikkilä P, Haglund C & Sariola H 2009 High frequency of SNAIL-expressing cells confirms and predicts metastatic potential of phaeochromocytoma. Endocrine-Related Cancer 16 1211-1218. (doi:10.1677/ERC-09-0049)
16. Hoogsteen IJ, Marres HA, Bussink J, van der Kogel AJ & Kaanders JH 2007 Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head & Neck 29 591-604. (doi:10.1002/hed.20543)
17. Kaelin WG 2007 Von Hippel-Lindau disease. Annual Review of Pathology 2 145-173. (doi:10.1146/annurev.pathol.2.010506.092049)
18. Katayama S, Tomaru Y, Kasukawa T, Waki K, Nakanishi M, Nakamura M, Nishida H, Yap CC, Suzuki M, Kawai J et al. 2005 Antisense transcription in the mammalian transcriptome. Science 309 1564-1566. (doi:10.1126/science.1112009)
19. de Kok JB, Roelofs RW, Giesendorf BA, Pennings JL, Waas ET, Feuth T, Swinkels DW & Span PN 2005 Normalization of gene expression measurements in tumor tissues: comparison of 13 endogenous control genes. Laboratory Investigation 85 154-159. (Pubitemid 40128049)
20. Lee S, Nakamura E, Yang H, Wei W, Linggi MS, Sajan MP, Farese RV, Freeman RS, Carter BD, Kaelin WG Jr et al. 2005 Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8 155-167. (doi:10.1016/j.ccr.2005.06.015)
21. Lenders JW, Eisenhofer G, Mannelli M & Pacak K 2005 Phaeochromocytoma. Lancet 366 665-675. (doi:10.1016/S0140-6736(05)67139-5)
22. Linnoila RI, Keiser HR, Steinberg SM & Lack EE 1990 Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features. Human Pathology 21 1168-1180. (doi:10.1016/0046-8177(90)90155-X)
23. Makalowska I, Lin CF & Makalowski W 2005 Overlapping genes in vertebrate genomes. Computational Biology and Chemistry 29 1-12. (doi:10.1016/j.compbiolchem.2004.12.006)
24. Manders P, Sweep FC, Tjan-Heijnen VC, Geurts-Moespot A, van Tienoven DT, Foekens JA, Span PN, Bussink J & Beex LV 2003 Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients. Clinical Cancer Research 9 6363-6370. (Pubitemid 38031821)
25. Mello CC & Conte D Jr 2004 Revealing the world of RNA interference. Nature 431 338-342. (doi:10.1038/nature02872)
26. Ogawa Y & Lee JT 2002 Antisense regulation in X inactivation and autosomal imprinting. Cytogenetic and Genome Research 99 59-65. (doi:10.1159/000071575)
27. Pouyssegur J & Mechta-Grigoriou F 2006 Redox regulation of the hypoxia-inducible factor. Biological Chemistry 387 1337-1346. (doi:10.1515/BC.2006.167)
28. Rougeulle C & Heard E 2002 Antisense RNA in imprinting: spreading silence through air. Trends in Genetics 18 434-437. (doi:10.1016/S0168-9525(02) 02749-X)
29. Selak MA, Armour SM, MacKenzie ED, Boulahbel H, Watson DG, Mansfield KD, Pan Y, Simon MC, Thompson CB & Gottlieb E 2005 Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell 7 77-85. (doi:10.1016/j.ccr.2004.11.022)
30. Suh I, Shibru D, Eisenhofer G, Pacak K, Duh QY, Clark OH & Kebebew E 2009 Candidate genes associated with malignant pheochromocytomas by genome-wide expression profiling. Annals of Surgery 250 983-990. (doi:10.1097/SLA. 0b013e3181b248bb)
31. Thrash-Bingham CA & Tartof KD 1999 aHIF: a natural antisense transcript overexpressed in human renal cancer and during hypoxia. Journal of the National Cancer Institute 91 143-151. (doi:10.1093/jnci/91.2.143)
32. Timmers HJ, Brouwers FM, Hermus AR, Sweep FC, Verhofstad AA, Verbeek AL, Pacak K & Lenders JW 2008 Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma. Endocrine-Related Cancer 15 1127-1133. (doi:10.1677/ERC-08- 0049)
33. Tufarelli C, Stanley JA, Garrick D, Sharpe JA, Ayyub H, Wood WG & Higgs DR 2003 Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nature Genetics 34 157-165. (doi:10.1038/ng1157)
34. Uchida T, Rossignol F, Matthay MA, Mounier R, Couette S, Clottes E & Clerici C 2004 Prolonged hypoxia differentially regulates hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha expression in lung epithelial cells: implication of natural antisense HIF-1alpha. Journal of Biological Chemistry 279 14871-14878. (doi:10.1074/jbc.M400461200)
35. Van Nederveen FH, Gaal J, Favier J, Korpershoek E, Oldenburg RA, de Bruyn EM, Sleddens HF, Derkx P, Rivière J, Dannenberg H et al. 2009 An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis. Lancet Oncology 10 764-771 . (doi:10.1016/S1470-2045(09)70164-0)
36. Wenger RH, Rolfs A, Spielmann P, Zimmermann DR & Gassmann M 1998 Mouse hypoxia-inducible factor-1alpha is encoded by two different mRNA isoforms: expression from a tissue-specific and a housekeeping-type promoter. Blood 91 3471-3480. (Pubitemid 28193901)
37. Yelin R, Dahary D, Sorek R, Levanon EY, Goldstein O, Shoshan A, Diber A, Biton S, Tamir Y, Khosravi R et al. 2003 Widespread occurrence of antisense transcription in the human genome. Nature Biotechnology 21 379-386. (doi:10.1038/nbt808)